Orexigen Therapeutics, Inc. Contracts & Agreements

138 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
DE
2006
Debtors Modified Amended Plan of Liquidation
Orexigen Therapeutics, Inc.
2019
Amendment to the Asset Purchase Agreement, dated as of July 26, 2018, by and between Orexigen Therapeutics, Inc. and Nalpropion Pharmaceuticals, Inc
Purchase Agreements
Orexigen Therapeutics, Inc.
2018
Asset Purchase Agreement, dated as of April 23, 2018, by and between Orexigen Therapeutics, Inc. and Nalpropion Pharmaceuticals, Inc. (Schedules and exhibits have been omitted...
Exchange Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
NY
2018
Key Employee Incentive Plan
Bonus & Incentive Agreements
Orexigen Therapeutics, Inc.
2018
Instrument of Resignation, Appointment and Acceptance, dated as of March 20, 2018, by and among Orexigen Therapeutics, Inc., Wilmington Savings Fund Society, FSB and U.S. Bank...
Note Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
DE
2018
Debtor in Possession Credit and Security Agreement, dated as of March 12, 2018, by and between the Company, Wilmington Trust, National Association, as administrative agent, and...
Credit Agreements
Orexigen Therapeutics, Inc.
2018
Form of Exchange Agreement
Exchange Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
NY
2017
Fourth Amendment to Lease dated October 25, 2016 by and between Orexigen Therapeutics, Inc. and the Regents of the University of California
Lease Agreements
Orexigen Therapeutics, Inc.
2017
Fifth Amendment to Lease dated September 11, 2017 by and between Orexigen Therapeutics, Inc. and the Regents of the University of California
Lease Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2017
Form of Performance Retention Agreement
Bonus & Incentive Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2017
Amendment No. 3 to Second Amended and Restated Employment Agreement dated October 13, 2017 by and between the Registrant and Michael A. Narachi
Employment Agreements
Orexigen Therapeutics, Inc.
2017
Amendment No. 3 to Employment Agreement dated October 13, 2017 by and between the Registrant and Thomas Cannell
Employment Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2017
Amendment No. 2 to Employment Agreement dated October 13, 2017 by and between the Registrant and Thomas Lynch
Employment Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2017
Amendment No. 3 to Employment Agreement dated October 13, 2017 by and between the Registrant and Jason Keyes
Employment Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2017
Employment Agreement dated February 23, 2015 by and between the Registrant and Peter Flynn
Employment Agreements
Orexigen Therapeutics, Inc.
2017
Amendment No. 1 to Employment Agreement dated February 26, 2016 by and between the Registrant and Peter Flynn
Employment Agreements
Orexigen Therapeutics, Inc.
2017
Amendment No. 2 to Employment Agreement dated June 16, 2016 by and between the Registrant and Peter Flynn
Employment Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2017
Amendment No. 3 to Employment Agreement dated October 13, 2017 by and between the Registrant and Peter Flynn
Employment Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2017
Orexigen Therapeutics, Inc. Shares of Common Stock (par value$0.001 per share) Controlled Equity OfferingSM Sales Agreement
Stock Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
NY
2017
OREXIGEN THERAPEUTICS, INC. asissuer U.S. BANK NATIONAL ASSOCIATION INDENTURE Dated as ofFebruary 23, 2017 2.75% CONVERTIBLE EXCHANGE SENIOR NOTES DUE 2020 Table of Contents
Indenture Agreements
Orexigen Therapeutics, Inc.
2017
OREXIGEN THERAPEUTICS, INC. asissuer U.S. BANK NATIONAL ASSOCIATION INDENTURE Dated as ofFebruary 23, 2017 2.75% CONVERTIBLE EXCHANGE SENIOR NOTES DUE 2020 Table of Contents
Indenture Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
DE
2017
SECONDSUPPLEMENTAL INDENTURE
Indenture Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
NY
2017
FIRST SUPPLEMENTAL INDENTURE
Indenture Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
NY
2016
EMPLOYMENT AGREEMENT
Employment Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
CA
2016
OREXIGEN THERAPEUTICS, INC. AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT FEBRUARY 2, 2016
Employment Agreements
Orexigen Therapeutics, Inc.
2016
OREXIGEN THERAPEUTICS, INC. AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT JUNE 16, 2016
Employment Agreements
Orexigen Therapeutics, Inc.
2016
OREXIGEN THERAPEUTICS, INC. AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT JUNE 16, 2016
Employment Agreements
Orexigen Therapeutics, Inc.
2016
OREXIGEN THERAPEUTICS, INC. AMENDED AND RESTATED 2007 EQUITY INCENTIVE AWARD PLAN ARTICLE 1 PURPOSE
Bonus & Incentive Agreements
Orexigen Therapeutics, Inc.
2016
OREXIGEN THERAPEUTICS, INC. AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT FEBRUARY 4,2016
Employment Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2016
OREXIGEN THERAPEUTICS, INC. AMENDMENT NO. 2 TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT FEBRUARY 5, 2016
Employment Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2016
EMPLOYMENT AGREEMENT
Employment Agreements
Orexigen Therapeutics, Inc.
2016
OREXIGEN THERAPEUTICS, INC. AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT FEBRUARY 2, 2016
Employment Agreements
Orexigen Therapeutics, Inc.
2016
EMPLOYMENT AGREEMENT
Employment Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
CA
2016
OREXIGEN THERAPEUTICS, INC. AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT FEBRUARY 2, 2016
Employment Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2016
EMPLOYMENT AGREEMENT
Employment Agreements
Orexigen Therapeutics, Inc.
2016
OREXIGEN THERAPEUTICS, INC. AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT FEBRUARY 26, 2016
Employment Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2016
SEPARATION AGREEMENT BY AND BETWEEN OREXIGEN THERAPEUTICS, INC. AND TAKEDAPHARMACEUTICAL COMPANY LIMITED DATED MARCH 15, 2016
Separation Agreements
Orexigen Therapeutics, Inc.
2016
OREXIGEN THERAPEUTICS, INC. Performance Stock Unit Award Agreement
Bonus & Incentive Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2016
OREXIGEN THERAPEUTICS, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee and Collateral Agent INDENTURE Dated as ofMarch 21, 2016 0% Convertible Senior Secured Notes due 2020...
Indenture Agreements
Orexigen Therapeutics, Inc.
2016
SECURITY AGREEMENT among OREXIGENTHERAPEUTICS, INC., as Issuer, and THE GUARANTORSPARTY HERETO FROM TIME TO TIME, as Guarantors and U.S. BANK NATIONALASSOCIATION, as Collateral...
Security Agreements
Orexigen Therapeutics, Inc.
2016
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Orexigen Therapeutics, Inc.
2016
INVESTOR RIGHTSAGREEMENT BY AND AMONG OREXIGEN THERAPEUTICS, INC., BAUPOST GROUP SECURITIES, L.L.C., AND THE OTHERINVESTORS PARTY HERETO DATED AS OF MARCH 15, 2016 TABLE OF...
Orexigen Therapeutics, Inc.
2016
OREXIGEN THERAPEUTICS, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee and Collateral Agent INDENTURE Dated as of March[], 2016 0% Convertible Senior Secured Notes due 2020...
Indenture Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
DE
2016
FORM OF WARRANT
Warrant Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
NY
2016
[FORM OF FACE OF NOTE] [INCLUDEFOLLOWING LEGEND IF A GLOBAL NOTE]
Note Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
NY
2016
SECURITY AGREEMENT among OREXIGENTHERAPEUTICS, INC., as Issuer, and THE GUARANTORSPARTY HERETO FROM TIME TO TIME, as Guarantors and U.S. BANK NATIONALASSOCIATION, as Collateral...
Security Agreements
Orexigen Therapeutics, Inc.
2016
AMENDED AND RESTATED COLLABORATION AGREEMENT BY AND BETWEEN OREXIGEN THERAPEUTICS, INC. AND TAKEDAPHARMACEUTICAL COMPANY LIMITED DATED July 31, 2015
Collaboration Agreements
Orexigen Therapeutics, Inc.
2015
OREXIGENTHERAPEUTICS, INC. CONSULTING AGREEMENT
Consulting Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
CA
2015
THIRD AMENDMENT TO LEASE
Lease Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2015
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
CA
2015
AMENDEDAND RESTATED NALTREXONE HYDROCHLORIDE SUPPLY AGREEMENT
Supply Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
NY
2015
OREXIGENTHERAPEUTICS, INC. CONSULTING AGREEMENT
Consulting Agreements
Orexigen Therapeutics, Inc.
2015
EXHIBIT A OPTION GRANTS
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
CA
2015
AMENDMENT NO. 2 TO MANUFACTURING SERVICES AGREEMENT SEPTEMBER 11, 2014
Services Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2015
CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THEOMITTED MATERIAL HAS BEEN FILED SEPARATELY...
Exchange Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2014
OREXIGEN THERAPEUTICS, INC. Recoupment Policy Acknowledgement
Orexigen Therapeutics, Inc.
2014
NALTREXONE HYDROCHLORIDE SUPPLY AGREEMENT
Supply Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
NY
2014
AMENDMENT NUMBER 1 TO COLLABORATION AGREEMENT
Collaboration Agreements
Orexigen Therapeutics, Inc.
2014
AMENDMENT NO. 1 TO MANUFACTURING SERVICES AGREEMENT NOVEMBER 1, 2013
Services Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2014
OREXIGEN THERAPEUTICS, INC. AS ISSUER 2.75% CONVERTIBLE SENIORNOTES DUE 2020 INDENTURE DATED AS OF DECEMBER 6,2013 WILMINGTON TRUST, NATIONAL ASSOCIATION AS TRUSTEE TABLE OF...
Indenture Agreements
Orexigen Therapeutics, Inc.
2013
OREXIGEN THERAPEUTICS, INC. INDEPENDENT DIRECTOR COMPENSATION POLICY (AS AMENDED AND RESTATED EFFECTIVE AUGUST 27, 2013)
Compensation Agreements
Orexigen Therapeutics, Inc.
2013
EXHIBIT A AMENDMENT TO OREXIGEN THERAPEUTICS, INC. 2007 EQUITY INCENTIVEAWARD PLAN
Orexigen Therapeutics, Inc.
2013
OREXIGEN THERAPEUTICS, INC. AMENDMENT NO. 4 TO AMENDED AND RESTATEDEMPLOYMENT AGREEMENT FEBRUARY 15, 2013
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2013
OREXIGEN THERAPEUTICS, INC. AMENDMENT NO. 1 TO AMENDED AND RESTATEDEMPLOYMENT AGREEMENT FEBRUARY 15, 2013
Orexigen Therapeutics, Inc.
2013
OREXIGEN THERAPEUTICS, INC. AMENDMENT NO. 1 TO SECOND AMENDED ANDRESTATED EMPLOYMENT AGREEMENT FEBRUARY 15, 2013
Employment Agreements
Orexigen Therapeutics, Inc.
2013
SECOND AMENDMENT TO LEASE
Lease Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2013
OREXIGEN THERAPEUTICS, INC. INDEPENDENT DIRECTOR COMPENSATION POLICY (AS AMENDED AND RESTATED EFFECTIVE NOVEMBER 29, 2012)
Compensation Agreements
Orexigen Therapeutics, Inc.
2013
11,000,000 Shares OREXIGEN THERAPEUTICS, INC. Common Stock, par value $0.001 per share UNDERWRITING AGREEMENT
Underwriting Agreements
Orexigen Therapeutics, Inc.
2012
PARTIAL LEASE TERMINATION AGREEMENT (Torrey Pines Court, SanDiego, California)
Lease Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
DE
2012
OREXIGEN THERAPEUTICS, INC. AMENDMENT NO. 3 TO AMENDED AND RESTATEDEMPLOYMENT AGREEMENT MARCH 15, 2012
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2012
OREXIGEN THERAPEUTICS, INC. (a Delaware corporation) 5,646,173 Units Each Unit Consisting of One Share of Common Stock And A Warrant to Purchase Ten Shares of Common Stock...
Warrant Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
DE
2011
OREXIGEN THERAPEUTICS, INC. WARRANT TO PURCHASE COMMON STOCK
Warrant Agreements
Orexigen Therapeutics, Inc.
2011
OREXIGEN THERAPEUTICS, INC. AMENDMENT NO. 2 TO AMENDED AND RESTATEDEMPLOYMENT AGREEMENT NOVEMBER 1, 2011
Orexigen Therapeutics, Inc.
2011
OREXIGEN THERAPEUTICS, INC. AMENDMENT NO. 2 TO AMENDED AND RESTATEDEMPLOYMENT AGREEMENT NOVEMBER 1, 2011
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2011
AMENDMENT NO. 3 to the LICENSE AGREEMENT dated as of March 31, 2004 (as amended prior to the date hereof)
License Agreements
Orexigen Therapeutics, Inc.
2011
SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
CA
2011
OREXIGEN THERAPEUTICS, INC. AMENDMENT NO. 1 TO AMENDED ANDRESTATED EMPLOYMENT AGREEMENT JUNE , 2011
Employment Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2011
AMENDED AND RESTATED LICENSE AGREEMENT
License Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
NY
2011
OREXIGEN THERAPEUTICS, INC. KEY EXECUTIVE EMPLOYEE RETENTION BONUS PLAN APPROVED BY THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS ON MARCH 2, 2011
Bonus & Incentive Agreements
Orexigen Therapeutics, Inc.
2011
EXHIBIT A SEPARATION DATE REAFFIRMATION (To be signed on or within 21 days after the Separation Date.)
Separation Agreements
Orexigen Therapeutics, Inc.
2011
COLLABORATION AGREEMENT BY AND BETWEEN OREXIGEN THERAPEUTICS, INC. AND TAKEDA PHARMACEUTICAL COMPANY LIMITED DATED SEPTEMBER 1, 2010 TABLE OFCONTENTS
Collaboration Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
CA
2010
AMENDMENTNO. 1 TO LICENSE AGREEMENT
License Agreements
Orexigen Therapeutics, Inc.
2010
AMENDED AND RESTATED MASTER AGREEMENT FOR PHARMACEUTICAL DEVELOPMENT SERVICES
Development Agreements
Orexigen Therapeutics, Inc.
2010
Manufacturing Services Agreement March 12, 2010 Table of Contents
Services Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
DE
2010
BUPROPION HYDROCHLORIDE SUPPLY AGREEMENT
Supply Agreements
Orexigen Therapeutics, Inc.
2010
OREXIGEN THERAPEUTICS, INC. INDEPENDENT DIRECTORCOMPENSATION POLICY
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2010
OREXIGEN THERAPEUTICS, INC. 2007 EQUITY INCENTIVEAWARD PLAN ARTICLE 1 PURPOSE
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
DE
2010
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
Orexigen Therapeutics, Inc.
2010
EMPLOYMENT AGREEMENT
Employment Agreements
Orexigen Therapeutics, Inc.
2010
OREXIGEN THERAPEUTICS, INC. 2007 EQUITY INCENTIVEAWARD PLAN ARTICLE 1 PURPOSE
Orexigen Therapeutics, Inc.
2009
OREXIGEN THERAPEUTICS, INC. AMENDMENT NO. 1 TOAMENDED AND RESTATED EMPLOYMENT AGREEMENT OCTOBER 30, 2009
Employment Agreements
Orexigen Therapeutics, Inc.
2009
LICENSE AGREEMENT
License Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
NY
2009
OREXIGEN THERAPEUTICS, INC. (a Delaware corporation) 10,000,000 Shares of Common Stock
Stock Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
NY
2009
EMPLOYMENT AGREEMENT
Employment Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
CA
2009
EMPLOYMENT AGREEMENT
Employment Agreements
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
CA
2009
[Remainder of This Page Intentionally Left Blank]
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
CA
2009
RESIGNATION AGREEMENT
Orexigen Therapeutics, Inc.
2008
FIRST AMENDMENT TO LEASE
Lease Agreements
Orexigen Therapeutics, Inc.
2008
EMPLOYMENT AGREEMENT
Employment Agreements
Orexigen Therapeutics, Inc.
2008
OREXIGEN THERAPEUTICS, INC. (a Delaware corporation) 7,000,000 Shares of Common Stock PURCHASE AGREEMENT
Stock Agreements
Orexigen Therapeutics, Inc.
2008
Product Candidate
Orexigen Therapeutics, Inc.
2008
Exhibit No
Orexigen Therapeutics, Inc.
2008
Entry into a Material Definitive Agreement
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2007
Entry into a Material Definitive Agreement
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
CA
2007
Number of Shares
Orexigen Therapeutics, Inc.
2007
Exhibit No
Orexigen Therapeutics, Inc.
2007
Exhibit No
Orexigen Therapeutics, Inc.
2007
Exhibit No
Orexigen Therapeutics, Inc.
2007
Exhibit No
Orexigen Therapeutics, Inc.
2007
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
2007
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
2007
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
2007
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
2007
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
2007
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
2007
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
2007
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
2007
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
2007
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
2007
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
2007
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
2007
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
2007
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
2007
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
CA
2006
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
CA
2006
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
NC
2006
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2006
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
CA
2006
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
DE
2006
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
2006
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2006
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
DE
2006
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2006
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2006
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
2006
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
PA
2006
On an intent-to-treat basis, which includes all randomized patients who recorded at least one post-baseline body weight measurement, Contrave demonstrated mean weight loss of 4.0%...
Orexigen Therapeutics, Inc.
Health Care Equipment & Supplies
NC
2006